Development, feasibility and acceptability of a self-efficacy-enhancing smartphone application among pregnant women with gestational diabetes mellitus: single- arm pilot clinical trial
Abstract Background There is growing attention to the use of mHealth technologies to promote glycemic control for women with GDM around the world, but research on promoting a change in health behaviors is lacking. This study aimed to document the process of designing, developing, and testing the fea...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2022-04-01
|
| Series: | BMC Pregnancy and Childbirth |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12884-022-04684-1 |
| _version_ | 1818523702509174784 |
|---|---|
| author | Iman Al Hashmi Hilal Alsabti Omar Al Omari Yusra Al Nasseri Atika Khalaf |
| author_facet | Iman Al Hashmi Hilal Alsabti Omar Al Omari Yusra Al Nasseri Atika Khalaf |
| author_sort | Iman Al Hashmi |
| collection | DOAJ |
| description | Abstract Background There is growing attention to the use of mHealth technologies to promote glycemic control for women with GDM around the world, but research on promoting a change in health behaviors is lacking. This study aimed to document the process of designing, developing, and testing the feasibility and acceptability of the SEESPA. Methods This single-arm pilot clinical trial study included 15 pregnant women with GDM. Following SEESPA development (e.g., goal setting and action plan, role modeling, motivational messages, mastery of experiences, and tracking healthy behaviors), all participants were provided access to use the SEESPA for 4 weeks. Feasibility outcomes assessed were rates of recruitment, retention rate, success rate of transmitting motivational text messages, rate of participants acknowledging receipt of text messages, and success rate of recording healthy behaviors. Acceptability outcomes were determined by asking open-ended questions through telephone interview at 4-week post-intervention. Results Fifteen randomly selected women consented to participate in the study, with a 60.0% (n = 9) retention rate at post-trial intervention and 40.0% (n = 6) trial dropout. Two motivational text messages per week were sent to all participants. Of these, 68.1% were acknowledged by the participants. Study participants reported that SEESPA is useful, effective, and they felt satisfied about it. In addition, they brought few suggestions that will be integrated on the final version of the app. Conclusions and Clinical Relevance. The developed innovative SEESPA is a feasible and acceptable intervention for behavioral modifications among women with GDM, and is ready to be tested in a larger RCT study which is expected to inform the health policymakers to integrate SEESPA with the antenatal health care practice of women with GDM, specifically in developing countries where there is a greater risk of developing GDM complications among mothers and their infants. Trial registration. The study is registered on September 16, 2019 (ACTRN12619001278123p) by the Australian New Zealand Clinical Trials Registry. |
| first_indexed | 2024-12-11T05:48:05Z |
| format | Article |
| id | doaj.art-e22aac25987946b1af99681e7f700246 |
| institution | Directory Open Access Journal |
| issn | 1471-2393 |
| language | English |
| last_indexed | 2024-12-11T05:48:05Z |
| publishDate | 2022-04-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Pregnancy and Childbirth |
| spelling | doaj.art-e22aac25987946b1af99681e7f7002462022-12-22T01:18:55ZengBMCBMC Pregnancy and Childbirth1471-23932022-04-0122111510.1186/s12884-022-04684-1Development, feasibility and acceptability of a self-efficacy-enhancing smartphone application among pregnant women with gestational diabetes mellitus: single- arm pilot clinical trialIman Al Hashmi0Hilal Alsabti1Omar Al Omari2Yusra Al Nasseri3Atika Khalaf4College of Nursing, Sultan Qaboos UniversitySultan Qaboos University Hospital, Sultan Qaboos UniversityCollege of Nursing, Sultan Qaboos UniversityOman College of Health Sciences, Nursing Program, Ministry of HealthCollege of Nursing, Sultan Qaboos UniversityAbstract Background There is growing attention to the use of mHealth technologies to promote glycemic control for women with GDM around the world, but research on promoting a change in health behaviors is lacking. This study aimed to document the process of designing, developing, and testing the feasibility and acceptability of the SEESPA. Methods This single-arm pilot clinical trial study included 15 pregnant women with GDM. Following SEESPA development (e.g., goal setting and action plan, role modeling, motivational messages, mastery of experiences, and tracking healthy behaviors), all participants were provided access to use the SEESPA for 4 weeks. Feasibility outcomes assessed were rates of recruitment, retention rate, success rate of transmitting motivational text messages, rate of participants acknowledging receipt of text messages, and success rate of recording healthy behaviors. Acceptability outcomes were determined by asking open-ended questions through telephone interview at 4-week post-intervention. Results Fifteen randomly selected women consented to participate in the study, with a 60.0% (n = 9) retention rate at post-trial intervention and 40.0% (n = 6) trial dropout. Two motivational text messages per week were sent to all participants. Of these, 68.1% were acknowledged by the participants. Study participants reported that SEESPA is useful, effective, and they felt satisfied about it. In addition, they brought few suggestions that will be integrated on the final version of the app. Conclusions and Clinical Relevance. The developed innovative SEESPA is a feasible and acceptable intervention for behavioral modifications among women with GDM, and is ready to be tested in a larger RCT study which is expected to inform the health policymakers to integrate SEESPA with the antenatal health care practice of women with GDM, specifically in developing countries where there is a greater risk of developing GDM complications among mothers and their infants. Trial registration. The study is registered on September 16, 2019 (ACTRN12619001278123p) by the Australian New Zealand Clinical Trials Registry.https://doi.org/10.1186/s12884-022-04684-1DiabetesIntervention researchHealth behaviorsPregnancyInformation technologySelf-efficacy |
| spellingShingle | Iman Al Hashmi Hilal Alsabti Omar Al Omari Yusra Al Nasseri Atika Khalaf Development, feasibility and acceptability of a self-efficacy-enhancing smartphone application among pregnant women with gestational diabetes mellitus: single- arm pilot clinical trial BMC Pregnancy and Childbirth Diabetes Intervention research Health behaviors Pregnancy Information technology Self-efficacy |
| title | Development, feasibility and acceptability of a self-efficacy-enhancing smartphone application among pregnant women with gestational diabetes mellitus: single- arm pilot clinical trial |
| title_full | Development, feasibility and acceptability of a self-efficacy-enhancing smartphone application among pregnant women with gestational diabetes mellitus: single- arm pilot clinical trial |
| title_fullStr | Development, feasibility and acceptability of a self-efficacy-enhancing smartphone application among pregnant women with gestational diabetes mellitus: single- arm pilot clinical trial |
| title_full_unstemmed | Development, feasibility and acceptability of a self-efficacy-enhancing smartphone application among pregnant women with gestational diabetes mellitus: single- arm pilot clinical trial |
| title_short | Development, feasibility and acceptability of a self-efficacy-enhancing smartphone application among pregnant women with gestational diabetes mellitus: single- arm pilot clinical trial |
| title_sort | development feasibility and acceptability of a self efficacy enhancing smartphone application among pregnant women with gestational diabetes mellitus single arm pilot clinical trial |
| topic | Diabetes Intervention research Health behaviors Pregnancy Information technology Self-efficacy |
| url | https://doi.org/10.1186/s12884-022-04684-1 |
| work_keys_str_mv | AT imanalhashmi developmentfeasibilityandacceptabilityofaselfefficacyenhancingsmartphoneapplicationamongpregnantwomenwithgestationaldiabetesmellitussinglearmpilotclinicaltrial AT hilalalsabti developmentfeasibilityandacceptabilityofaselfefficacyenhancingsmartphoneapplicationamongpregnantwomenwithgestationaldiabetesmellitussinglearmpilotclinicaltrial AT omaralomari developmentfeasibilityandacceptabilityofaselfefficacyenhancingsmartphoneapplicationamongpregnantwomenwithgestationaldiabetesmellitussinglearmpilotclinicaltrial AT yusraalnasseri developmentfeasibilityandacceptabilityofaselfefficacyenhancingsmartphoneapplicationamongpregnantwomenwithgestationaldiabetesmellitussinglearmpilotclinicaltrial AT atikakhalaf developmentfeasibilityandacceptabilityofaselfefficacyenhancingsmartphoneapplicationamongpregnantwomenwithgestationaldiabetesmellitussinglearmpilotclinicaltrial |